Therefore, to address the question, “How does FBP1 promote cancer progression, and could targeting FBP1 be a potential therapeutic approach?”, we review the specific mechanisms of FBP1 in regulating tumor progression and drug resistance and explored the application of FBP1 as a new diagnostic biomarker and therapeutic target in tumor therapy. The gene discussed is FBP1; the disease is neoplasm.